Bolt Projects Holdings Inc (NASDAQ: BSLK) is a biotechnology company that develops bio-based ingredient alternatives to silicone elastomers for the beauty and personal care industry. Revenue is generated through the sale of ingredients from its Vegan Silk Technology Platform to beauty and cosmetic manufacturers. The company completed a business combination on August 13, 2024, bringing the legacy Bolt Threads operations into the public entity. As of December 31, 2024, Bolt had an accumulated deficit of $461.8 million and recorded a net loss of $65.4 million for the year ended December 31, 2024, reflecting its pre-commercial stage. In early 2023, the company discontinued all other product candidates to concentrate entirely on the Vegan Silk Technology Platform. Manufacturing is outsourced to a network of third-party fermentation specialists, with Bolt retaining responsibility for research, development, scaling, technical transfers, branding, and commercialization.

Revenue model

Ingredient sales to beauty and cosmetic manufacturers from the Vegan Silk Technology Platform. The company targets lower loading levels than silicone elastomers, which it positions as a cost-of-goods advantage for formulators. Revenue model is transactional; no subscription or royalty structure is disclosed in the 10-K filed 2025-03-18.

Products and services

Vegan Silk Technology Platform: bio-based ingredients produced via fermentation using materials such as yeast, sugar, and water, designed as alternatives to silicone elastomers in personal care and cosmetic formulations. The platform targets the roughly 390,000 tons of silicone products sold annually in the personal care and consumer products sector, as cited by the Global Silicone Council in the 10-K filed 2025-03-18.

Customers and end markets

Beauty and cosmetic manufacturers, including large-scale formulators of personal care products. End market is the global personal care and consumer products sector. No specific named customers or customer concentration data are disclosed in the excerpts from the 10-K filed 2025-03-18.

Value-chain role

Ingredient supplier and technology licensor sitting upstream of finished product formulators. Research, development, scaling, and commercialization are kept in-house; physical manufacturing is delegated to third-party fermentation specialists.

Geographic exposure

No specific geographic revenue breakdown is disclosed in the excerpts from the 10-K filed 2025-03-18. The filing references exposure to U.S. trade policy and international markets generally.

Source: SEC 10-K, filed 2025-03-18

Industry: Industrial Organic Chemicals